Clinical validity of the Mattis dementia rating scale-2 in Parkinson disease with MCI and dementia

Journal of Geriatric Psychiatry and Neurology

Volumn 25, Issue 2, 2012, Pages 100-106

  Matteau, Evelyne ^a   Dupré, Nicolas ^b,c   Langlois, Mélanie ^b,c   Provencher, Pierre ^c   Simard, Martine ^a  

^a CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

dementia; dementia rating scale; mild cognitive impairment; Parkinson disease; screening; validity

Indexed keywords

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; ATTENTION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; FEMALE; GENDER; HUMAN; MALE; MATTIS DEMENTIA RATING SCALE 2; MEMORY; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PERSEVERATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VALIDITY;

AGED; AGED, 80 AND OVER; ATTENTION; CROSS-SECTIONAL STUDIES; DEMENTIA; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84862245267     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988712445086     Document Type: Article

References (45)

1. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006;5(3):235-245. (Pubitemid 43238347)
2. Aarsland D, Kurz MW. The epidemiology of dementia associated with Parkinson disease. J Neurol Sci. 2010;289(1-2):18-22.
3. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183-194. (Pubitemid 39222988)
4. Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G. Cognitive impairment in incident, untreated Parkinson disease. Neurology. 2009;72(13):1121-1126.
5. Janvin CC, Larsen JP, Aarsland D, Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord. 2006;21(9):1343-1349. (Pubitemid 44613283)
6. Caviness JN, Driver-Dunckley E, Connor DJ, et al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord. 2007; 22(9):1272-1277. (Pubitemid 47325034)
7. Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2001;70(6):734-738. (Pubitemid 32554202)
8. Schrag A, Barone P, Brown RG, et al. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2007;22(8):1077-1092. (Pubitemid 47067217)
9. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003;60(3):387-392. (Pubitemid 36314364)
10. Burn DJ, McKeith IG. Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease. Mov Disord. 2003;18(suppl 6):S72-S79. (Pubitemid 37185199)
11. Riedel O, Klotsche J, Spottke A, et al. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German study on epidemiology of parkinson's disease with dementia (GEPAD). J Neurol. 2008;255(2):255-264.
12. Mamikonyan E, Moberg PJ, Siderowf A, et al. Mild cognitive impairment is common in Parkinson's disease patients with normal mini-mental state examination (MMSE) scores. Parkinsonism Relat Disord. 2009;15(3):226-231.
13. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699. (Pubitemid 41623495)
14. Dalrymple-Alford JC, Macaskill MR, Nakas CT, et al. The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology. 2010;75(19):1717-1725.
15. Coblentz JM, Mattis S, Zingesser LH, Kasoff SS, Wisniewski HM, Katzman R. Presenile dementia. Clinical aspects and evaluation of cerebrospinal fluid dynamics. Arch Neurol. 1973;29(5):299-308.
16. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak T, Karasi TB, eds. Geriatric Psychiatry. New York, NY: Crane and Stratten; 1976:77-121.
17. Aarsland D, Litvan I, Salmon D, Galasko D, Wentzel-Larsen T, Larsen JP. Performance on the Dementia Rating Scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003;74(9):1215-1220.
18. Llebaria G, Pagonabarraga J, Kulisevsky J, et al. Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease. Mov Disord. 2008;23(11):1546-1550.
19. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007;22(16): 2314-2324. (Pubitemid 351155975)
20. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 1992;42(6):1142-1146.
21. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology. 2001; 57(8):1497-1499. (Pubitemid 32995738)
22. Delis DC, Kaplan E, Kramer JH. Delis-Kaplan Executive Function System. San Antonio, TX: The Psychological Corporation; 2001.
23. Weschler D. Weschler Adult Intelligence Scale. 3rd ed. San Antonio, TX: The Psychological Corporation; 1997.
24. Delis DC, Kramer JH, Kaplan EF, Ober BA. California Verbal Learning Test: Adult Version Manual. San Antonio, TX: The Psychological Corporation; 1987.
25. Cahn DA, Salmon DP, Monsch AU, et al. Screening for dementia of the Alzheimer type in the community: the utility of the clock drawing test. Arch Clin Neuropsychol. 1996;11(6):529-539. (Pubitemid 26300088)
26. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427-442.
27. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278-296.
28. Leentjens AF, Verhey FR, Lousberg R, Spitsbergen H, Wilmink FW. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. Int J Geriatr Psychiatry. 2000;15(7):644-649. (Pubitemid 30608443)
29. Mattis S. Dementia Rating Scale: Professional Manual. Odessa, FL: Psychological Assessment Resources; 1988.
30. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J Intern Med. 2004;256(3):240-246. (Pubitemid 39222993)
31. Fort I,Adoul L,Holl D,Kaddour J,Gana K. Psychometric properties of the French version of themultifactorialmemory questionnaire for adults and the elderly. Can J Aging. 2004;23(4):347-357. (Pubitemid 40269384)
32. Gauthier S, Gelinas I, Gauthier L. Functional disability in Alzheimer's disease. Int Psychogeriatr. 1997;9(suppl 1):163-165. (Pubitemid 28045355)
33. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007;22(12):1689-1707; quiz 837.
34. Warner J. Clinicians' guide to evaluating diagnostic and screening tests in psychiatry. Adv Psychiat Treatment. 2004; 10(6):446-454. (Pubitemid 39504584)
35. Jaeschke R, Guyatt G, Lijmer J. Diagnostic tests. In: Guyatt G, Rennie D, eds. User's Guides to the Medical Literature. Chicago, IL: American Medical Association Press; 2002:121-140.
36. Hoops S, Nazem S, Siderowf AD, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 2009;73(21):1738-1745.
37. Pagonabarraga J, Kulisevsky J, Llebaria G, Garcia-Sanchez C, Pascual-Sedano B, Gironell A. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease. Mov Disord. 2008;23(7):998-1005.
38. Schmidt K. Dementia Rating Scale-2: Alternate Form Supplemental Manual. Lutz, Fla: Psychological Assessment Resources, Inc.; 2004.
39. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the quality standards subcommittee of the American academy of neurology. Neurology. 2001;56(9): 1133-1142.
40. Mahieux F, Fenelon G, Flahault A, Manifacier MJ, Michelet D, Boller F. Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1998;64(2): 178-183. (Pubitemid 28159798)
41. Bohnen NI, Kaufer DI, Hendrickson R, et al. Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia. J of Neurol. 2006;253(2):242-247. (Pubitemid 43255898)
42. Woods SP, Troster AI. Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease. J Int Neuropsychol Soc. 2003;9(1):17-24. (Pubitemid 36150134)
43. Song IU, Kim JS, Jeong DS, Song HJ, Lee KS. Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia. Parkinsonism Relat Disord. 2008; 14(7):558-562.
44. Kulisevsky J, Pagonabarraga J. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment. Mov Disord. 2009;24(8):1103-1110.
45. Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairment in in Parkinson's disease: movement disorder society task force guidelines. Mov Disord. 2012;27(3): 349-356. doi: 10.1002/mds.24893.